Illumina Picks BioDiscovery Software for CytoSeq Assay Data Visualization | GenomeWeb

NEW YORK (GenomeWeb) – BioDiscovery announced today that it has signed a collaborative agreement to provide its NxClinical data visualization software to Illumina.

Under the terms of the agreement, NxClinical will be the secondary data analysis and management tool for Illumina's CytoSeq assay. The software will be offered as an interactive tool for visualization and interpretation of genomic events, the firms said, and will directly read CytoSeq results to process data and provide results.

Financial and other details were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.